What happened: On September 29, 2026, Allergan Aesthetics announced that Health Canada had authorized Boey (trenibotulinumtoxinE) for the temporary improvement in the appearance of moderate to severe frown lines in adults. Allergan describes it as the first rapid-onset, short-duration botulinum toxin serotype E authorized for this use.
How it differs from the toxins you already use
Every neurotoxin used in Canadian aesthetics until now has been a type A toxin: onabotulinumtoxinA (Botox), abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin) and prabotulinumtoxinA (Nuceiva). Type A products take a few days to show and last three to four months. Boey is the opposite on both counts:
| Boey (trenibotulinumtoxinE) | Type A neurotoxins | |
|---|---|---|
| Serotype | E | A |
| Onset | As early as 8 hours | Usually 2–5 days |
| Duration | About 2–3 weeks | About 3–4 months |
| Pivotal dose | 700 units total | Product-specific (e.g. 20 units Botox for glabellar lines) |
| Authorized use | Moderate to severe frown lines, adults | Frown lines and other indications, product-specific |
What the trials showed
Allergan’s release cites two randomized, double-blind, placebo-controlled Phase 3 studies (M21-500 and M21-508) in 947 patients treated with 700 units or placebo. At day 7, 60% and 65.7% of patients on Boey achieved at least a two-grade improvement in frown line severity, assessed by both investigator and patient. The adverse reactions reported were eyelid ptosis and brow ptosis (uncommon) and the “Mephisto sign”, a peaked lateral brow (rare). The full safety information is in the Canadian product monograph.
These figures come from the manufacturer’s announcement. Read the product monograph before treating.
What it changes in your practice
Units are not interchangeable. A 700-unit dose of a type E toxin has no relationship to 20 units of Botox. Any unit converter you use, including ours, applies to type A products only. The biggest documentation risk with a new toxin is a record that says “units” without a product name.
Record the product, lot and expiry every time. If you stock Boey alongside a type A toxin, each dispense needs the brand, the lot number and the expiry against the patient, so a recall or an unexpected reaction can be traced. Our guide to charting injectable treatments covers the fields colleges expect.
Update consent. A short duration is the point of the product, so the consent conversation should say so plainly: the effect fades within weeks, and repeat treatment is a choice, not a failure. If your neurotoxin consent names specific products, add Boey before you use it. See our Botox consent form template.
Ask about availability. The announcement doesn’t give a Canadian launch date or pricing. Confirm with your Allergan representative, and check the Drug Product Database for the DIN before ordering.
Comparing neurotoxins
For how the type A products compare on units, onset, duration and price per unit in Canada, see our Botox vs Dysport, Xeomin, Daxxify and Jeuveau comparisons.
